A study showed both global and specific deletion of the IL-23 receptor (IL-23R) in CD4+ T cells reduced IL-17 production but did not improve atherosclerosis in Ldlr−/− mice given a 10-week HFD [105]. Here, IL17A is linked to atherosclerosis.